Zalevsky Jonathan
Nektar Therapeutics · Chief R&D Officer
Zalevsky Jonathan is listed in filings as Chief R&D Officer at Nektar Therapeutics. This profile follows SEC Form 4 activity through May 21, 2026, including sale activity. Recent filings connect the profile to Nektar Therapeutics (NKTR). The current snapshot covers public activity from Aug 20, 2024 to May 21, 2026. Reported amounts are shown as $13.0K to $137.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $13k180 shares | SellFeb 18, 2026 | $73.00 | $68.30 | |
| $138k3.9k shares | SellJan 20, 2026 | $35.67 | $68.30 | |
| $63k1.2k shares | SellNov 25, 2025 | $54.28 | $68.30 | |
| $26k793 shares | SellSep 4, 2025 | $32.43 | $68.30 | |
| $15k432 shares | SellSep 4, 2025 | $33.60 | $68.30 | |
| $11k307 shares | SellSep 4, 2025 | $35.69 | $68.30 | |
| $6.5k189 shares | SellSep 4, 2025 | $34.41 | $68.30 | |
| $15k485 shares | SellSep 2, 2025 | $30.10 | $68.30 | |
| $19k725 shares | SellAug 19, 2025 | $26.59 | $68.30 | |
| $7.2k10.7k shares | SellMay 19, 2025 | $0.67 | $68.30 | |
| $10k10.3k shares | SellFeb 19, 2025 | $1.01 | $68.30 | |
| $48k51.1k shares | SellDec 19, 2024 | $0.94 | $68.30 | |
| $7.9k7.8k shares | SellNov 19, 2024 | $1.01 | $68.30 | |
| $8.8k6.9k shares | SellAug 19, 2024 | $1.28 | $68.30 |